These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17509528)

  • 1. Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of coxsackievirus replication.
    Wong J; Zhang J; Si X; Gao G; Luo H
    Biochem Biophys Res Commun; 2007 Jul; 358(3):903-7. PubMed ID: 17509528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.
    Lin YW; Yang JL
    J Biol Chem; 2006 Jan; 281(2):915-26. PubMed ID: 16286470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.
    Kassel O; Sancono A; Krätzschmar J; Kreft B; Stassen M; Cato AC
    EMBO J; 2001 Dec; 20(24):7108-16. PubMed ID: 11742987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK regulation upon contact inhibition in fibroblasts.
    Wayne J; Sielski J; Rizvi A; Georges K; Hutter D
    Mol Cell Biochem; 2006 Jun; 286(1-2):181-9. PubMed ID: 16467968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV impairs TNF-alpha release in response to Toll-like receptor 4 stimulation in human macrophages in vitro.
    Tachado SD; Zhang J; Zhu J; Patel N; Koziel H
    Am J Respir Cell Mol Biol; 2005 Dec; 33(6):610-21. PubMed ID: 16109884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation.
    Brondello JM; Pouysségur J; McKenzie FR
    Science; 1999 Dec; 286(5449):2514-7. PubMed ID: 10617468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW; Huang SC; Lin-Shiau SY; Lin JK
    Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MKP-1 contributes to oxidative stress-induced apoptosis via inactivation of ERK1/2 in SH-SY5Y cells.
    Kim GS; Choi YK; Song SS; Kim WK; Han BH
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1732-8. PubMed ID: 16289033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling.
    Kusari AB; Byon J; Bandyopadhyay D; Kenner KA; Kusari J
    Mol Endocrinol; 1997 Sep; 11(10):1532-43. PubMed ID: 9280068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A balances the growth factor-induced Ras/ERK signaling.
    Pursiheimo JP; Kieksi A; Jalkanen M; Salmivirta M
    FEBS Lett; 2002 Jun; 521(1-3):157-64. PubMed ID: 12067709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
    Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
    J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.
    Shi H; Zeng C; Ricome A; Hannon KM; Grant AL; Gerrard DE
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1681-9. PubMed ID: 17151143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.